Chris Bostick is a Vice President at OCV. Prior to OCV Dr. Bostick obtained his Ph.D. in Pharmaceutical and Pharmacological Sciences from West Virginia University researching protein immobilization for studying electron transfer and protein-protein interactions in Cytochrome P450s. For his postdoctoral work, he studied precision medicine-based approaches for genetic epilepsies at the Institute for Genomic Medicine at Columbia University. Dr. Bostick holds a B.S. in Biology from Cornell University and a Ph.D. in Pharmacological and Pharmaceutical Sciences from West Virginia University.
Chris serves as a Board Observer for Ossio.